2024 annual financial data
Viridian Therapeutics 2024 Operating margin
Direct answer
Operating margin was -99,018.21%.
Operating income was -299,035,000 USD and net income was -269,949,000 USD.
Operating cash flow was -232,319,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 302,000 USD
- Operating income
- -299,035,000 USD
- Net income
- -269,949,000 USD
- Operating cash flow
- -232,319,000 USD